Elevated serum soluble CD200 and CD200R as surrogate markers of bone loss under bed rest conditionsElevated serum soluble CD200 and CD200R as surrogate markers of bone loss under bed rest conditions
Faculty of Sciences. Physics
Biophysics and Biomedical Physics
2014New York, 2014
Bone / International Bone and Mineral Society. - New York
60(2014), p. 33-40
University of Antwerp
CD200 is a transmembrane protein that belongs to the immunoglobulin family of proteins and is ubiquitously expressed on a variety of cell types. Upon interaction with its receptors (CD200R5) expressed on myeloid-derived cells and T lymphocytes, an immunoregulatory signal is delivered to receptor-expressing cells. Previous studies have implicated a role for CD200:CD200R in the regulation of the expression of mRNA markers of osteoclastogenesis/osteoblastogenesis, following interaction of CD200 (on osteoblast precursors) with CD200R1 (on osteoclast precursors). Signaling of CD200R1 is hypothesized to attenuate osteoclastogenesis. We have investigated whether levels of soluble forms of CD200 and/or CD200R1 (sCD200, 5CD200R1) are altered in volunteers undergoing 6 head down tilt bed rest to mimic conditions of microgravity known to be associated with preferential osteoclastogenesis and whether countermeasures, reported to be beneficial in attenuation of bone loss under microgravity conditions, would lead to altered sCD200 and 5CD200R1 levels. Our data suggest that as predicted, sCD200 levels fall under bed rest conditions while sCD200R1 levels rise. In subjects undergoing 30-minute per day continuous centrifugation protocols, as a countermeasure to attenuate changes which may lead to bone loss, these alterations in 5CD200 and sCD200R1 levels seen under conditions of bed rest were abolished or attenuated. Our results suggest that measurement of 5CD200 and/or sCD200R1 May prove a useful and rapid means of monitoring subjects at risk of bone loss and/or accessing the efficacy of treatment regimes designed to counter bone loss. (C) 2013 Elsevier Inc. All rights reserved.